Palpable Adenopathy Does Not Indicate High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer
CONCLUSIONS: A substantial minority of patients with cT1-3N1 HR+/HER2- disease with palpable adenopathy had two or fewer positive nodes on ALND. Standard clinicopathologic features and ultrasound findings can help identify candidates for upfront sentinel lymph node biopsy as a strategy to avoid ALND. Prospective studies evaluating this approach are warranted.PMID:33876360 | DOI:10.1245/s10434-021-09943-7
Source: Ann Oncol - Category: Cancer & Oncology Authors: Angelena Crown Varadan Sevilimedu Monica Morrow Source Type: research
More News: Breast Cancer | Breast Conservation Surgery | Breast Lumpectomy | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | HER2 | Hormones | Lumpectomy | Mastectomy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Ultrasound